Related Experiment Video
Updated: Aug 16, 2026

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis
Published on: December 9, 2022
Pathophysiology of mifepristone-induced septic shock due to Clostridium sordellii
1Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown Medical School, Brown University, 174 Meeting St., Providence, RI 02912-9107, USA. Ralph_Miech@brown.edu
Objective:
To explain the role of mifepristone in medical abortions that results in fulminant and lethal septic shock due to Clostridium sordellii.
Data Sources:
MEDLINE, PubMed, and Google Scholar databases were searched (1984-March 2005). Key search terms were mifepristone, RU38486, RU486, Mifeprex, medical abortion, septic shock, innate immune system, cytokines, and Clostridium sordellii.
Study Selection And Data Extraction:
All articles identified from the data sources were evaluated and all information deemed relevant was included for the information related to the development of the understanding of the pathophysiology of mifepristone-induced septic shock due to C. sordellii.
Data Synthesis:
The mechanisms of action of mifepristone were incorporated into the pathophysiology of septic shock due to C. sordellii. Mifepristone, by blocking both progesterone and glucocorticoid receptors, interferes with the controlled release and functioning of cortisol and cytokines. Failure of physiologically controlled cortisol and cytokine responses results in an impaired innate immune system that results in disintegration of the body's defense system necessary to prevent the endometrial spread of C. sordellii infection. The abnormal cortisol and cytokine responses due to mifepristone coupled to the release of potent exotoxins and an endotoxin from C. sordellii are the major contributors to the rapid development of lethal septic shock.
Conclusions:
Theoretically, it appears that the mechanisms of mifepristone action favor the development of infection that leads to septic shock and intensifies the actions of multiple inflammatory cytokines, resulting in fulminant, lethal septic shock.
Insights
Mifepristone use in medical abortions may increase the risk of lethal septic shock from Clostridium sordellii by impairing the immune system. This drug interferes with cortisol and cytokine responses, allowing infection to spread rapidly.
Area of Science:
- Reproductive Medicine
- Infectious Diseases
- Pharmacology
Background:
- Medical abortion utilizes mifepristone, a progesterone and glucocorticoid receptor antagonist.
- Rare but severe cases of septic shock due to Clostridium sordellii have been associated with mifepristone use.
- Understanding the pathophysiology is crucial for patient safety and risk mitigation.
Purpose of the Study:
- To elucidate the role of mifepristone in the development of fulminant and lethal septic shock caused by Clostridium sordellii.
- To explore the immunological mechanisms underlying mifepristone-associated septic shock.
Main Methods:
- Comprehensive literature search of MEDLINE, PubMed, and Google Scholar (1984-2005).
- Inclusion of all relevant articles detailing the pathophysiology of mifepristone-induced septic shock by C. sordellii.
- Synthesis of information on drug mechanisms and infectious agent toxins.
Main Results:
- Mifepristone disrupts cortisol and cytokine regulation by blocking progesterone and glucocorticoid receptors.
- This disruption impairs the innate immune system, compromising defenses against endometrial C. sordellii infection.
- Combined effects of mifepristone's actions and C. sordellii toxins lead to rapid, lethal septic shock.
Conclusions:
- Mifepristone's mechanism of action theoretically promotes C. sordellii infection and septic shock development.
- The drug intensifies inflammatory cytokine responses, contributing to fulminant and lethal septic shock.
- Further research into the interaction between mifepristone and C. sordellii is warranted.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Intestinal Obstruction II: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Dysbiosis of the Gut Microbiota
Mechanism of Antibiotic Resistance in MRSA
Urinary Tract Infection II: Pathophysiology

